We are live on ! Find out more
GG

Gofen & Glossberg Portfolio holdings

AUM $3.89B
1-Year Est. Return 11.97%
This Fund
S&P 500
This Quarter Est. Return
+0.83%
1 Year Est. Return
-11.97%
3 Year Est. Return
+36.4%
5 Year Est. Return
+73.95%
10 Year Est. Return
–
AUM
$4.27B
AUM Growth
+$58.6M
Cap. Flow
+$41.8M
Cap. Flow %
0.98%
Top 10 Hldgs %
30.15%
Holding
635
New
55
Increased
206
Reduced
187
Closed
12

Top Buys

Rank Stock Value
1
ICSH icon
iShares Ultra Short Duration Bond Active ETF
ICSH
+$11.3M
2
STZ icon
Constellation Brands
STZ
+$8.51M
3
TENX icon
Tenax Therapeutics
TENX
+$6.25M
4
AMZN icon
Amazon
AMZN
+$3.51M
5
APD icon
Air Products & Chemicals
APD
+$2.52M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$2.68M
2
ASML icon
ASML
ASML
+$2.62M
3
IVOL icon
Quadratic Interest Rate Volatility and Inflation Hedge ETF
IVOL
+$2.5M
4
MSFT icon
Microsoft
MSFT
+$2.21M
5
TMO icon
Thermo Fisher Scientific
TMO
+$1.9M

Sector Composition

Rank Sector Weight
1 Technology 20.42%
2 Healthcare 15.39%
3 Financials 12.78%
4 Communication Services 9.02%
5 Consumer Staples 8.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GLAS
451
Glass House Brands
GLAS
$855M
$100K ﹤0.01%
+20,000
New +$100K
BCTX
452
Briacell Therapeutics
BCTX
$29.9M
$81K ﹤0.01%
+67
New +$61.6K
LFMD icon
453
LifeMD
LFMD
$169M
$76K ﹤0.01%
+12,250
New +$104K
QTNT
454
DELISTED
Quotient Limited Ordinary Shares
QTNT
$59K ﹤0.01%
+625
New +$78.1K
HELP
455
Cybin Inc
HELP
$485M
$55K ﹤0.01%
+658
New +$57.6K
NYMX
456
DELISTED
Nymox Pharmaceutical Corp
NYMX
$52K ﹤0.01%
25,000
– –
REUN
457
DELISTED
Reunion Neuroscience Inc. Common Shares
REUN
$46K ﹤0.01%
+2,000
New +$50.3K
GNLN icon
458
Greenlane Holdings
GNLN
$1.22M
– –
0
– –
IMCC
459
IM Cannabis
IMCC
$1.04M
$35K ﹤0.01%
+167
New +$42.2K
LFLYW
460
DELISTED
Leafly Holdings, Inc. Warrant
LFLYW
$30K ﹤0.01%
+25,000
New +$28.4K
DNN icon
461
Denison Mines
DNN
$2.54B
$29K ﹤0.01%
20,000
– –
NWBO
462
DELISTED
Northwest Biotherapeutics, Inc. Common stock
NWBO
$16K ﹤0.01%
12,740
– –
TNXP icon
463
Tonix Pharmaceuticals
TNXP
$160M
– –
0
– –
EVFM
464
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$7K ﹤0.01%
+667
New +$8.38K
OTEX icon
465
Open Text
OTEX
$6.15B
– –
-4,000
Closed -$203K
TMUS icon
466
T-Mobile US
TMUS
$185B
– –
-1,866
Closed -$270K
TWLO icon
467
Twilio
TWLO
$30B
– –
-600
Closed -$236K
VTEB icon
468
Vanguard Tax-Exempt Bond Index Fund
VTEB
$45.1B
– –
-4,005
Closed -$221K
XBI icon
469
State Street SPDR S&P Biotech ETF
XBI
$9.95B
– –
-1,510
Closed -$204K
EAR
470
DELISTED
Eargo, Inc. Common Stock
EAR
– –
-363
Closed -$290K
15 16 17 18
19

Similar funds

AIM
Allstate Investment Management Chicago, Illinois $3.29B AUM
AAM
Abeille Asset Management France $2.82B AUM 15.24% 1-Year Est. Return
ZCA
Zeke Capital Advisors Berwyn, Pennsylvania $1.53B AUM 17.37% 1-Year Est. Return
GJIC
Gamble Jones Investment Counsel Pasadena, California $1.33B AUM 11.55% 1-Year Est. Return
SBL
Sargent Bickham Lagudis Boulder, Colorado $1.22B AUM 14.94% 1-Year Est. Return
RCAMU
Rothschild & Co Asset Management US Stamford, Connecticut $6.58B AUM 4.5% 1-Year Est. Return
TFS
TrustCore Financial Services Brentwood, Tennessee $1.14B AUM 13.32% 1-Year Est. Return
S
Seeyond Paris, France $1.03B AUM 9.64% 1-Year Est. Return

Gofen & Glossberg's Q3 2021 Portfolio in Review

As of Q3 2021, Gofen & Glossberg held 635 positions worth $4.27B, up 1.4% from $4.21B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Gofen & Glossberg's Q3 2021 filing shows 55 new, 206 increased, 187 reduced and 12 closed positions. Its largest new stake was Tenax Therapeutics: 2,387 shares worth $6.76M. The largest sale was Apple, an estimated $2.68M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • Gofen & Glossberg's largest Q3 2021 buy was Tenax Therapeutics: 2,387 shares worth $6.76M.
  • Gofen & Glossberg added most to iShares Ultra Short Duration Bond Active ETF in Q3 2021, an estimated $11.3M increase.
  • Gofen & Glossberg's biggest Q3 2021 reduction was Apple, cutting an estimated $2.68M.
  • Gofen & Glossberg fully exited Eargo, Inc. Common Stock in Q3 2021, selling an estimated $290K.
  • Gofen & Glossberg's ten largest holdings make up 30% of its $4.27B portfolio in Q3 2021.
  • Gofen & Glossberg opened 55 new positions and closed 12 in Q3 2021.
  • Gofen & Glossberg's portfolio value rose 1.4% quarter-over-quarter to $4.27B.

Based on Gofen & Glossberg's 13F filing for Q3 2021, filed 13 Oct 2021.